The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 36

More JCP Articles

JCP
Safety and Tolerability of Concomitant Intranasal Esketamine and MAOI Treatment
Case Report

February 1, 2023

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in some patients.
, , , et al
JCP
Ketamine vs Esketamine for TRD
Original Research

February 1, 2023

Are ketamine and esketamine equally efficacious? This observational study compares the efficacy of subanesthetic intravenous ketamine with that of intranasal esketamine for treatment-resistant depression in a real-world clinical setting.
, , , et al
JCP
Effect of Zuranolone on Anxiety and Insomnia in Postpartum Depression
Original Research

January 30, 2023

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived functional health in patients with PPD.
, , , et al
JCP
Prolactin, Antipsychotics, and Fracture Risk
Clinical and Practical Psychopharmacology

January 30, 2023

Fracture risk associated with antipsychotics may be related to whether they increase prolactin. If long-term treatment with prolactin-raising agents is necessary, prolactin levels should be regularly monitored.
JCP
Young-Adult Social Outcomes of ADHD
Original Research

January 25, 2023

ADHD that persisted into young-adulthood was associated with poorer outcomes in terms of education, employment, and emotional support.
, , , et al
JCP
Effects of ECT in Comorbid Depression and Dementia
Original Research

January 25, 2023

Limited data suggest a role for electroconvulsive therapy (ECT) in treating behavioral and psychological symptoms of dementia. Using a larger sample size than in previous reports, this study examined…
, , , et al
JCP
Managing Obstructive Sleep Apnea in Psychiatric Practice
Systematic Review

January 23, 2023

As shown in this review, OSA may be a risk factor for the development of psychiatric conditions, as well as suicidal ideation and attempts.
, , , et al
JCP
The Emerging Treatment Landscape in Schizophrenia
Commentary

January 18, 2023

This article provides an overview of emerging therapies poised to transform the treatment paradigm for patients with living with schizophrenia.
,
JCP
Schizophrenia: Salient Symptoms and Pathophysiology
Commentary

January 18, 2023

This article notes the distinction between positive and negative schizophrenic symptoms and provides an updated overview of disease pathophysiology.
JCP
Adverse Events and Treatment Adherence in Schizophrenia
Commentary

January 18, 2023

This article examines the effects of treatment-related adverse events on adherence to medication and strategies to improve adherence in practice.
,
JCP
The Epidemiology and Global Burden of Schizophrenia
Commentary

January 18, 2023

This article explores the costs and burden of schizophrenia and provides an overview of disease prevalence, incidence, and trends over time.
,
JCP
Optimizing Therapy Selection, Sequencing in Schizophrenia
Commentary

January 18, 2023

This article summarizes the current treatment landscape in schizophrenia, along with contexts in which agents should be prescribed.
,

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe